Daric Barton gets cortisone shot in shoulder, unlikely to be ready for Opening Day

Leave a comment

Oakland’s first base/corner outfield/designated hitter logjam won’t include Manny Ramirez for at least 50 games and may also be lessened by Daric Barton’s shoulder problems.

Barton, who underwent surgery to repair a partially torn labrum in September, received a second cortisone injection this morning and will be shut down for at least a few days.

Jane Lee of MLB.com speculates that his odds of beginning the season on the active roster are now pretty long and Barton was bad enough last season that he was in a fight for his job anyway.

Brandon Allen had a seven-RBI game yesterday and looks like the favorite to be the Opening Day first baseman in Oakland.

Clayton Kershaw completes spring training with a 0.00 ERA

Getty Images

Clayton Kershaw had nothing left to prove when he exited the mound during his last Cactus League start on Friday. He finished camp with a 0.00 ERA, made all the more impressive after he extended his scoreless streak to 21 1/3 innings following 6 2/3 frames of one-hit ball against the Royals.

In six spring training starts this year, the Dodgers southpaw racked up 12 hits, four walks and 23 strikeouts. His velocity appeared to fluctuate between the high-80s and low-90s from start to start, but manager Dave Roberts told reporters that he expects Kershaw to get back up to the 93 m.p.h. range next week. Kershaw is tabbed for his eighth consecutive Opening Day start on Thursday.

The 30-year-old lefty is poised to enter his 11th season with the club in 2018. He went 18-4 in 27 starts last year and turned in a 2.31 ERA, 1.5 BB/9 and 10.4 SO/9 over 175 innings. He suffered his fair share of bumps and bruises along the way, including a lower back strain that required a five-week stay on the disabled list.

The Dodgers will open their season against the Giants on Thursday, March 29 at 7:08 PM ET. Given the sudden rash of injuries that hit the Giants’ rotation earlier today, Kershaw’s Opening Day opponent has not yet been announced.